Roles of macrophages in tumor immunotherapy: metabolism, immune checkpoints, and combination strategies.

Authors

Shan Wang, Yage Fu, Yamei Huang

Published in

Journal of Zhejiang University. Science. B. Volume 27. Issue 10. Pages 1096-1116. Sep 22, 2026. Epub Sep 22, 2026.

Abstract

Macrophages influence anti-tumor immunity through tractable metabolic and checkpoint programs. Within hypoxic, nutrient-competitive tumor beds, tumor-associated macrophages (TAMs) adopt oxidative and lipid-based metabolisms, dampening antigen presentation and T-cell support. Converging evidence shows that lactate flux, fatty acid oxidation (FAO), and glutamine handling steer TAMs toward immunosuppressive states that blunt checkpoint efficacy. Here, we synthesize the mechanism by which discrete pathways-glycolysis/pentose phosphate pathway (PPP) switching, FAO-lysosomal lipolysis, and glutamine-α-ketoglutarate signaling-mechanistically reprogram TAMs. We then map these circuits onto combination strategies involving programmed cell death (ligand) protein 1/cytotoxic T-lymphocyte antigen-4 (PD-(L)1/CTLA-4) blockade, chemotherapy/radiotherapy, and chimeric antigen receptor T-cell (CAR-T). Rather than providing a catalogue, we emphasize when metabolic rewiring dominates, which TAM subsets are affected, and how these levers can be timed or co-inhibited to restore cytotoxic T-cell function. This approach provides operational guidance for pairing macrophage-directed agents with immune checkpoint inhibitors in solid tumors.

PMID:
42928018
Bibliographic data and abstract were imported from PubMed on 26 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.